David Gordon
2021 - Aclaris Therapeutics
In 2021, David Gordon earned a total compensation of $2.9M as Former Chief Medical Officer at Aclaris Therapeutics, a 284% increase compared to previous year.
Compensation breakdown
Option Awards | $1,606,689 |
---|---|
Salary | $424,453 |
Stock Awards | $683,304 |
Other | $206,663 |
Total | $2,921,109 |
Gordon received $1.6M in option awards, accounting for 55% of the total pay in 2021.
Gordon also received $424.5K in salary, $683.3K in stock awards and $206.7K in other compensation.
Rankings
In 2021, David Gordon's compensation ranked 4,527th out of 12,405 executives tracked by ExecPay. In other words, Gordon earned more than 63.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,527 | 64th |
Manufacturing | 1,871 | 66th |
Chemicals And Allied Products | 777 | 67th |
Drugs | 691 | 67th |
Pharmaceutical Preparations | 492 | 68th |
Gordon's colleagues
We found four more compensation records of executives who worked with David Gordon at Aclaris Therapeutics in 2021.
News
Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
April 21, 2022
Coffee Holding Co CEO Andrew Gordon's 2021 pay slips 10% to $380K
February 28, 2022
Coffee Holding Co CEO Andrew Gordon's 2020 pay falls 66% to $421K
March 29, 2021
Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
April 23, 2020
Coffee Holding Co CEO Andrew Gordon's 2019 pay jumps 220% to $1.2M
February 28, 2020
Coffee Holding Co Secretary David Gordon's 2018 pay rises 2% to $389K
February 28, 2019